Get 20% lifetime commission for referring investors to digrin.com
here.
Lineage Cell Therapeutics, Inc. ( LCTX) - Key Metrics
LCTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | $0.01 | -$0.03 | -$0.03 |
| 2026Q1 | $0.01 | -$0.02 | -$0.03 | -$0.03 |
| 2025Q4 | $0.03 | $0 | -$0.02 | -$0.02 |
| 2025Q3 | $0.02 | -$0.13 | -$0.02 | -$0.02 |
| 2025Q2 | $0.01 | -$0.13 | -$0.02 | -$0.02 |
LCTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 55.51 |
| 2026Q1 | 0% | -20.15 |
| 2025Q4 | 0% | 119.29 |
| 2025Q3 | 0% | -3.25 |
| 2025Q2 | 0% | -1.74 |
LCTX
Price: $0.98
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.19 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 400600
Market Capitalization: 236.2 million